Samrat Pharmachem Ltd scheduled a Board meeting on May 30, 2026 to approve FY26 audited standalone financial results.
The meeting will be held at 2:00 PM at the Corporate Office in Andheri (West), Mumbai, under Regulation 29 of SEBI LODR.
Audited results under Ind-AS will be shared with exchanges, press, and company website post board approval.